EVIDENCE THAT THERAPEUTIC STRATEGIES TARGETED AT CD4+ CELLS MODULATE ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN SENSITIZED RATS BY DIFFERENT MECHANISMS
Tomasz Sablinski(Icahn School of Medicine at Mount Sinai), Jerzy W. Kupiec‐Weglinski(Harvard University), Mohamed H. Sayegh(American University of Beirut), JEAN P. KUT(Kidney Associates), Nicholas L. Tilney(Harvard University), Edgar L. Milford(Brigham and Women's Hospital)
Cited by 7
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Immunomodulation by Mesenchymal Stem Cells
|Diabetes|2008|470
EFFECTS OF EXPLOSIVE BRAIN DEATH ON CYTOKINE ACTIVATION OF PERIPHERAL ORGANS IN THE RAT1
|Transplantation|1998|404
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383
Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance
|The Journal of Experimental Medicine|1998|340